Target Audience

This activity is specifically designed for:

  • Country regulators

  • Policy makers

  • Implementing partners

  • Funders

Learning Objectives

At the end of the course, learners should be able to:

  • Provide latest global perspectives and advocacy on implementation of LF-LAM testing

  • Highlight barriers and solutions for achieving and maintaining widespread coverage of LF-LAM testing

  • Provide practical support for LF-LAM implementation through sharing of country experiences and lessons learned


The purpose of this course is to inform best practices for implementation of LF-LAM testing at scale. Addressing these issues, the agenda is as follows:

  • Increasing adoption and scale-up of LAM testing

  • Overview of normative guidance and FAQs

  • Roll out of TB LAM testing in Zimbabwe, experiences and lessons learnt

  • Nigeria’s LF-LAM experience

  • Malawi: Scale-up of LAM in inpatient settings

  • Ensuring quality of TB LAM testing: A new practical toolkit

  • Integration of TB LAM with other TB and advanced HIV diagnostics

Course Directors

Laura Broyles, MD, The Global Health Impact Group, US

Patricia Hall-Eidson, PhD, International Laboratory Branch/CDC Atlanta, US


  • Wayne van Gemert, STOP TB, Geneva

  • Ajay Rangaraj, WHO HQ, Geneva

  • Blessing Mushangwe, Zim-TTECH, Zimbabwe

  • Peter Nwaokenneya, Federal Ministry of Health, Nigeria

  • Justin Nwofe, APIN Public Health Initiative, Nigeria

  • Billy Banda, Ministry of Health, Malawi

  • Subhadra Nandakumar, International Laboratory Branch/CDC Atlanta, US

  • Didas Tugumisirize, Ministry of Health, Uganda

Learn more!

Add your email to the mailing list to get the latest updates.